Mahkam Zanganeh Salary and Compensation - Summit Therapeutics Inc. CEO Salary 2025

In fiscal year 2025, Mahkam Zanganeh, Co-Chief Executive Officer, President and Director of Summit Therapeutics Inc. (SMMT), received total compensation of $246.0 million.

Mahkam Zanganeh's compensation breakdown includes: base salary of $617K, bonus of $388K, option awards of $245.0 million, and other compensation of $21K.

Compared to fiscal year 2024, Mahkam Zanganeh's total compensation increased 21092% from $1.2 million to $246.0 million.

Summit Therapeutics Inc. (SMMT) Executive Pay 2025

Summit Therapeutics Inc.'s top 3 named executive officers received combined total compensation of $495.3 million in fiscal year 2025.

The named executive officers disclosed in Summit Therapeutics Inc.'s 2025 proxy statement are:Mahkam Zanganeh (Co-Chief Executive Officer, President and Director) with total compensation of $246.0 million, Robert W. Duggan (Co-Chief Executive Officer and Chairman) with total compensation of $172K, and Manmeet Soni (Chief Operating Officer, Chief Financial Officer and Director) with total compensation of $249.1 million.